Significantly, tumor samples from patients who underwent surgical resection after CAR T cell infusion revealed upregulation of IDO1 and increased T regulatory cells, implying the possibility of GBM escape mechanisms reinstating an immunosuppressive milieu. The gene discussed is IDO1; the disease is glioblastoma.